CBR International is a full-service product development, clinical oversight, and strategic regulatory operations group providing comprehensive "lab to launch" program development services. CBR provides comprehensive product development services to the biotechnology, pharmaceutical, and device industries worldwide. We have a proven track record of successful FDA meetings and approvals. Our teams have the expertise to support your projects over their entire lifetimes, all the way from preclinical development through approval and post-marketing. CBR is currently assisting clients with COVID-19 development programs and we are very familiar with the FDA's Coronavirus Treatment Acceleration Program (CTAP). We are assisting clients through this process to accelerate products to the clinic. Please contact us if you need assistance or general advice: call us at 720-746-1190 or email info@cbrintl.com.